Chernin Ethan 4

What Happened

• Ethan Chernin, President of Health Services at Ardent Health, was recorded as acquiring 32,408 shares via an award/grant on 2026-03-11. The shares were reported at $0.00 per share (total reported value $0) as they reflect performance-based restricted stock units rather than an open-market purchase.

Key Details

• Transaction date: 2026-03-11; Filing date: 2026-03-13 (filed within the normal Form 4 reporting window).
• Transaction type/code: Award/Grant (A).
• Shares involved: 32,408 shares; reported price: $0.00; reported total value: $0.
• Shares owned after the transaction: not specified in the filing.
• Footnote: These shares were earned based on 2024 and 2025 performance under performance-vesting restricted stock units originally awarded on July 18, 2024. Per the award terms, the shares will vest on December 31, 2026, contingent on Chernin’s continued service through that date.

Context

• This was a compensation-related award (performance-vested RSUs), not an open-market buy or sale. There was no immediate cash purchase or sale; vesting is contingent on service and prior performance metrics. Such awards are common executive compensation and do not by themselves indicate an immediate buying/selling signal.